Free Trial

Bakkt (BKKT) Financials

Bakkt logo
$5.58 -0.32 (-5.34%)
Closing price 10/16/2026 03:59 PM Eastern
Extended Trading
$5.63 +0.04 (+0.81%)
As of 10/16/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Bakkt

Annual Income Statements for Bakkt

This table shows Bakkt's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2020 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-80 -578 -75 -47 -107
Consolidated Net Income / (Loss)
-80 -1,990 -226 -103 -132
Net Income / (Loss) Continuing Operations
-80 -1,990 -154 -94 -98
Total Pre-Tax Income
-79 -2,001 -153 -94 -97
Total Operating Income
-79 -2,019 -156 -83 -148
Total Gross Profit
-15 -83 681 3,405 2,258
Total Revenue
28 56 727 3,441 2,335
Operating Revenue
28 56 727 3,441 2,335
Total Cost of Revenue
43 139 45 36 77
Operating Cost of Revenue
43 139 45 36 77
Total Operating Expenses
64 1,936 838 3,488 2,406
Selling, General & Admin Expense
25 66 54 50 45
Depreciation Expense
8.16 25 12 0.34 0.61
Other Operating Expenses / (Income)
3.08 2.83 726 3,428 2,354
Impairment Charge
15 1,834 37 0.74 0.73
Restructuring Charge
13 8.01 8.55 8.32 5.39
Total Other Income / (Expense), net
-0.10 18 2.95 -12 50
Interest Expense
-0.12 -1.88 -4.34 -4.32 -0.79
Other Income / (Expense), net
-0.22 16 -1.39 -16 50
Income Tax Expense
0.39 -11 0.36 0.11 -0.05
Other Gains / (Losses), net
- - 0.00 0.00 -0.32
Net Income / (Loss) Discontinued Operations
- - -72 -9.04 -35
Net Income / (Loss) Attributable to Noncontrolling Interest
0.00 -1,412 -151 -57 -25
Basic Earnings per Share
$0.00 ($203.08) ($21.01) ($7.97) ($8.87)
Weighted Average Basic Shares Outstanding
- 272.71M 328.82M 22.87M 30.56M
Diluted Earnings per Share
$0.00 ($203.08) ($21.01) ($7.97) ($8.87)
Weighted Average Diluted Shares Outstanding
- 272.71M 328.82M 22.87M 30.56M
Weighted Average Basic & Diluted Shares Outstanding
- 272.71M 328.82M 22.87M 30.56M

Quarterly Income Statements for Bakkt

This table shows Bakkt's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders
-27 -8.17 -16 -3.58 -18 7.71 -18 -16 -84 -12 -17
Consolidated Net Income / (Loss)
-79 -21 -36 -6.29 -40 16 -30 -23 -95 -12 81
Net Income / (Loss) Continuing Operations
-6.53 -21 -36 -3.76 -34 19 -27 -22 -62 -12 81
Total Pre-Tax Income
-6.58 -21 -35 -3.88 -34 19 -27 -22 -62 -11 81
Total Operating Income
-6.85 -32 -22 -25 -3.60 -15 -16 -25 -86 -17 -20
Total Gross Profit
202 830 488 -9.87 2,097 1,058 -10 -8.08 651 237 -6.96
Total Revenue
161 855 510 0.00 2,077 1,066 0.00 0.00 682 244 0.00
Total Cost of Revenue
-40 25 22 9.87 -21 7.79 10 8.08 31 6.60 6.96
Operating Cost of Revenue
-40 25 22 9.87 -21 7.79 10 8.08 31 6.60 6.96
Total Operating Expenses
181 862 510 16 2,100 1,073 8.84 18 736 254 12
Selling, General & Admin Expense
8.10 18 13 15 4.01 11 8.69 13 8.73 12 11
Depreciation Expense
1.49 0.06 0.12 0.11 0.06 0.22 0.15 0.15 0.08 0.07 1.05
Restructuring Charge
-13 6.14 0.93 0.43 0.83 0.23 0.00 5.11 0.05 0.00 0.00
Total Other Income / (Expense), net
0.27 11 -13 21 -30 35 -11 3.68 24 5.51 1.96
Interest Expense
-0.84 -0.96 -1.25 -1.01 -1.10 -0.62 0.05 0.05 -0.27 -0.19 -0.55
Interest & Investment Income
- - - - - - 0.00 - - - -0.28
Other Income / (Expense), net
-0.57 9.76 -15 20 -31 34 -11 3.73 23 5.32 1.70
Income Tax Expense
-0.05 0.16 0.07 -0.11 -0.01 0.05 0.08 -0.03 -0.13 0.01 0.01
Net Income / (Loss) Discontinued Operations
- - - -2.53 - -3.15 -3.26 -1.60 - 0.00 0.00
Net Income / (Loss) Attributable to Noncontrolling Interest
-52 -13 -19 -3.40 -21 8.53 -15 -8.24 -9.89 0.00 0.00
Basic Earnings per Share
($0.08) ($1.86) ($2.67) ($0.45) ($0.81) $1.18 ($2.16) ($1.15) ($2.76) ($0.41) $1.96
Weighted Average Basic Shares Outstanding
328.82M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M
Diluted Earnings per Share
($0.08) ($1.86) ($2.67) ($0.45) ($0.81) $1.13 ($2.16) ($1.15) ($2.76) ($0.41) $1.94
Weighted Average Diluted Shares Outstanding
328.82M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M
Weighted Average Basic & Diluted Shares Outstanding
328.82M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M

Annual Cash Flow Statements for Bakkt

This table details how cash moves in and out of Bakkt's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2020 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-1.19 -293 3.08 35 -109
Net Cash From Operating Activities
-31 -118 -61 -21 -153
Net Cash From Continuing Operating Activities
-31 -118 -61 -21 -153
Net Income / (Loss) Continuing Operations
-80 -1,990 -226 -103 -132
Consolidated Net Income / (Loss)
-80 -1,990 -226 -103 -132
Depreciation Expense
7.97 25 14 0.34 0.61
Non-Cash Adjustments To Reconcile Net Income
21 1,856 114 35 81
Changes in Operating Assets and Liabilities, net
19 -9.24 37 47 -103
Net Cash From Investing Activities
-7.93 -172 66 14 -38
Net Cash From Continuing Investing Activities
-7.93 -172 66 14 -38
Purchase of Property, Plant & Equipment
-21 -31 -9.43 -3.09 -1.17
Acquisitions
- 0.00 -49 0.00 -14
Purchase of Investments
- -307 -62 -18 -55
Divestitures
11 - 0.00 0.00 -16
Sale and/or Maturity of Investments
1.99 165 186 35 66
Other Investing Activities, net
- - 0.00 0.00 -18
Net Cash From Financing Activities
37 -2.58 -2.63 44 82
Net Cash From Continuing Financing Activities
37 -2.58 -2.63 44 82
Repayment of Debt
- - 0.00 0.00 -14
Issuance of Debt
- - 0.00 0.00 29
Issuance of Common Equity
38 0.00 0.00 47 63
Other Financing Activities, net
-0.31 0.00 -2.63 -2.69 4.78
Effect of Exchange Rate Changes
0.19 -0.85 0.44 -1.50 0.59
Cash Income Taxes Paid
0.00 0.00 0.24 0.00 0.00

Quarterly Cash Flow Statements for Bakkt

This table details how cash moves in and out of Bakkt's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents
-6.21 72 -54 -19 36 -97 28 -7.25 -32 57 -29
Net Cash From Operating Activities
-6.81 38 -66 -25 31 -101 5.35 -47 -11 -12 -15
Net Cash From Continuing Operating Activities
-6.81 38 -66 -25 31 -101 5.35 -47 -11 -12 -15
Net Income / (Loss) Continuing Operations
-79 -21 -36 -6.29 -40 16 -30 -23 -95 -12 81
Consolidated Net Income / (Loss)
-79 -21 -36 -6.29 -40 16 -30 -23 -95 -12 81
Depreciation Expense
3.09 0.06 0.12 0.11 0.06 0.22 0.15 0.15 0.08 0.07 1.05
Non-Cash Adjustments To Reconcile Net Income
71 -0.84 18 -19 34 -31 15 5.99 90 -1.16 -95
Changes in Operating Assets and Liabilities, net
-2.70 60 -49 0.49 37 -87 20 -30 -6.01 0.65 -1.56
Net Cash From Investing Activities
0.26 -2.30 4.30 5.90 6.24 -0.13 4.50 -20 -23 1.94 -14
Net Cash From Continuing Investing Activities
0.26 -2.30 4.30 5.90 6.24 -0.13 4.50 -20 -23 1.94 -14
Purchase of Property, Plant & Equipment
-1.53 -1.77 -0.46 -0.55 -0.31 -0.13 -0.02 -0.55 -0.46 -0.73 -1.51
Purchase of Investments
-17 -18 - -7.99 8.02 0.00 - -5.09 -50 -0.01 -9.66
Net Cash From Financing Activities
-0.13 37 7.49 -0.11 -0.26 4.10 17 60 0.73 67 0.45
Net Cash From Continuing Financing Activities
-0.13 37 7.49 -0.11 -0.26 4.10 17 60 0.73 67 0.45
Repurchase of Common Equity
- -2.26 -0.06 -0.11 -0.26 -0.91 -0.81 -1.71 - -2.82 -0.05
Other Financing Activities, net
-2.63 0.00 0.00 - - 0.00 - 7.46 -2.69 0.00 0.50
Effect of Exchange Rate Changes
0.47 -0.42 -0.20 - -1.13 0.03 0.89 - - 0.09 -0.04

Annual Balance Sheets for Bakkt

This table presents Bakkt's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2020 2021 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
468 2,414 456 265 269 163
Total Current Assets
132 464 326 181 184 72
Cash & Equivalents
75 391 98 53 39 27
Restricted Cash
17 17 17 65 113 15
Short-Term Investments
1.82 0.00 141 17 0.00 0.24
Accounts Receivable
10 18 25 30 7.68 12
Prepaid Expenses
0.73 32 23 13 3.97 2.75
Other Current Assets
27 4.78 22 3.33 20 15
Plant, Property, & Equipment, net
20 6.12 20 0.06 2.06 1.66
Total Noncurrent Assets
316 1,945 109 84 83 89
Long-Term Investments
- - - - 0.00 11
Goodwill
233 1,527 16 68 68 65
Intangible Assets
62 388 56 2.90 2.90 5.55
Other Noncurrent Operating Assets
21 29 38 13 13 7.57
Total Liabilities & Shareholders' Equity
468 2,414 456 265 269 163
Total Liabilities
59 120 119 130 207 50
Total Current Liabilities
51 74 92 101 138 33
Accounts Payable
45 65 67 55 14 15
Current Deferred Revenue
4.28 4.63 3.97 4.28 0.00 0.79
Other Current Liabilities
2.02 4.27 21 41 95 17
Total Noncurrent Liabilities
7.52 47 27 29 69 17
Other Noncurrent Operating Liabilities
3.32 30 24 26 63 17
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
0.00 2,294 336 136 63 113
Total Preferred & Common Equity
0.00 468 96 48 34 113
Total Common Equity
388 468 96 48 34 113
Common Stock
522 567 773 800 833 1,017
Retained Earnings
-113 -98 -676 -751 -798 -905
Accumulated Other Comprehensive Income / (Loss)
0.19 -0.06 -0.29 -0.10 -0.84 0.95

Quarterly Balance Sheets for Bakkt

This table presents Bakkt's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026
Total Assets
847 1,576 1,243 1,183 176 190 258 213 404
Total Current Assets
694 1,490 1,157 1,098 93 110 120 125 97
Cash & Equivalents
68 57 47 29 23 43 58 80 50
Restricted Cash
56 132 87 87 32 39 17 20 21
Short-Term Investments
23 18 13 6.73 - - 5.09 0.25 0.31
Accounts Receivable
22 37 24 27 29 23 13 9.53 11
Prepaid Expenses
12 9.17 5.94 5.62 2.54 2.07 3.96 1.67 0.92
Other Current Assets
513 1,237 979 943 6.51 2.29 23 14 14
Plant, Property, & Equipment, net
21 1.51 1.93 1.77 1.97 1.84 1.53 2.32 2.09
Total Noncurrent Assets
132 84 84 83 82 78 136 86 304
Long-Term Investments
- - - - - - 11 11 11
Goodwill
67 68 68 68 68 65 65 65 157
Intangible Assets
42 2.90 2.90 2.90 2.90 2.90 5.55 5.55 23
Other Noncurrent Operating Assets
24 13 13 12 11 10 55 4.93 114
Total Liabilities & Shareholders' Equity
847 1,576 1,243 1,183 176 190 258 213 404
Total Liabilities
636 1,445 1,140 1,081 95 132 130 43 49
Total Current Liabilities
594 1,398 1,077 1,042 58 93 54 30 31
Accounts Payable
49 63 39 42 38 43 18 13 9.85
Current Deferred Revenue
4.37 3.30 2.32 2.01 1.52 1.63 0.79 0.00 0.00
Other Current Liabilities
540 1,328 1,036 998 19 27 14 18 21
Total Noncurrent Liabilities
42 46 63 39 36 39 76 12 18
Other Noncurrent Operating Liabilities
39 43 60 36 34 37 71 12 18
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
211 131 103 102 82 58 129 171 354
Total Preferred & Common Equity
69 57 48 50 44 35 114 171 354
Total Common Equity
69 57 48 50 44 35 114 171 354
Common Stock
794 817 824 829 835 841 935 1,087 1,189
Retained Earnings
-725 -759 -776 -779 -790 -805 -820 -917 -836
Accumulated Other Comprehensive Income / (Loss)
-0.29 -0.32 -0.34 -0.22 -0.83 -0.40 -0.60 1.04 1.00

Annual Metrics And Ratios for Bakkt

This table displays calculated financial ratios and metrics derived from Bakkt's official financial filings.

Metric 2020 2022 2023 2024 2025
Period end date 12/31/2020 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding
25,921,502.00 271,176,053.00 563,610,314.00 20,811,835.00 31,178,817.00
DEI Adjusted Shares Outstanding
1,036,860.00 10,847,042.00 22,544,413.00 20,811,835.00 31,178,817.00
DEI Earnings Per Adjusted Shares Outstanding
-76.78 -53.30 -3.32 -2.24 -3.44
Growth Metrics
- - - - -
Revenue Growth
0.00% 0.00% 1,193.02% 373.33% -32.14%
EBITDA Growth
0.00% 0.00% 92.73% 31.61% 0.72%
EBIT Growth
0.00% 0.00% 92.13% 37.44% 0.45%
NOPAT Growth
0.00% 0.00% 92.26% 47.14% -79.01%
Net Income Growth
0.00% 0.00% 88.65% 54.19% -27.83%
EPS Growth
0.00% 0.00% 88.65% 62.07% -11.29%
Operating Cash Flow Growth
0.00% 0.00% 48.39% 65.07% -623.48%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 95.43% -15,578.26%
Invested Capital Growth
0.00% 0.00% -99.16% -8,407.90% 206.19%
Revenue Q/Q Growth
0.00% 0.00% 24.90% 125.52% -37.38%
EBITDA Q/Q Growth
0.00% 0.00% 68.92% -45.18% -38.82%
EBIT Q/Q Growth
0.00% 0.00% 67.17% -38.77% -38.52%
NOPAT Q/Q Growth
0.00% 0.00% 67.54% 3.79% -124.44%
Net Income Q/Q Growth
0.00% 0.00% 52.31% 27.03% -70.76%
EPS Q/Q Growth
0.00% 0.00% 52.31% -201.89% -566.92%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 21.77% 64.31% -37.97%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 6.76% -105.76% -69.32%
Invested Capital Q/Q Growth
0.00% -78.37% -98.95% -170.95% -5.01%
Profitability Metrics
- - - - -
Gross Margin
-51.40% -147.31% 93.74% 98.95% 96.69%
EBITDA Margin
-249.08% -3,517.68% -19.77% -2.86% -4.18%
Operating Margin
-277.66% -3,590.84% -21.49% -2.40% -6.33%
EBIT Margin
-278.42% -3,562.77% -21.68% -2.87% -4.20%
Profit (Net Income) Margin
-279.36% -3,539.30% -31.06% -3.01% -5.66%
Tax Burden Percent
100.49% 99.43% 147.30% 109.70% 135.78%
Interest Burden Percent
99.85% 99.91% 97.25% 95.62% 99.19%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
-17.53% -1,775.67% -272.54% 0.00% -5,993.89%
ROIC Less NNEP Spread (ROIC-NNEP)
-25.19% -1,550.83% -213.06% 0.00% -5,960.50%
Return on Net Nonoperating Assets (RNNOA)
0.00% 1,183.56% 176.82% 0.00% 5,843.31%
Return on Equity (ROE)
0.00% -592.11% -95.73% -104.19% -150.58%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% -75.89% 0.00% -368.98%
Operating Return on Assets (OROA)
-16.94% -139.60% -43.74% -36.89% -45.43%
Return on Assets (ROA)
-17.00% -138.68% -62.65% -38.69% -61.20%
Return on Common Equity (ROCE)
0.00% -127.11% -29.33% -43.12% -125.75%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-55 -1,413 -109 -58 -103
NOPAT Margin
-194.36% -2,513.59% -15.04% -1.68% -4.43%
Net Nonoperating Expense Percent (NNEP)
7.66% -224.85% -59.48% -35.99% -33.39%
Return On Investment Capital (ROIC_SIMPLE)
0.00% -420.51% -80.59% -91.98% -91.76%
Cost of Revenue to Revenue
151.40% 247.31% 6.26% 1.05% 3.31%
SG&A Expenses to Revenue
86.22% 117.96% 7.42% 1.46% 1.94%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
226.26% 3,443.53% 115.23% 101.35% 103.02%
Earnings before Interest and Taxes (EBIT)
-79 -2,003 -158 -99 -98
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-71 -1,978 -144 -98 -98
Valuation Ratios
- - - - -
Price to Book Value (P/BV)
0.67 3.35 13.02 15.21 2.78
Price to Tangible Book Value (P/TBV)
2.82 13.13 0.00 0.00 7.35
Price to Revenue (P/Rev)
9.17 5.74 0.86 0.15 0.13
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
0.53 3.85 865.60 0.00 4.38
Enterprise Value to Revenue (EV/Rev)
5.88 5.44 0.80 0.11 0.11
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00
Financial Leverage
0.00 -0.76 -0.83 -1.28 -0.98
Leverage Ratio
0.00 1.09 1.53 2.69 2.46
Compound Leverage Factor
0.00 1.09 1.49 2.57 2.44
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 71.36% 64.42% 46.07% 0.00%
Common Equity to Total Capital
0.00% 28.64% 35.58% 53.93% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00
Altman Z-Score
2.05 -14.23 0.09 9.12 8.62
Noncontrolling Interest Sharing Ratio
0.00% 78.53% 69.36% 58.62% 16.49%
Liquidity Ratios
- - - - -
Current Ratio
2.59 3.54 1.80 1.33 2.19
Quick Ratio
1.71 2.87 0.99 0.34 1.19
Cash Flow Metrics
- - - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 -30 -1.39 -218
Operating Cash Flow to CapEx
-150.42% -385.02% -643.45% -686.85% -13,144.73%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - -
Asset Turnover
0.06 0.04 2.02 12.87 10.81
Accounts Receivable Turnover
2.74 2.59 26.45 184.27 236.44
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.43 4.35 73.42 3,240.17 1,254.16
Accounts Payable Turnover
0.96 2.11 0.74 1.04 5.31
Days Sales Outstanding (DSO)
133.32 141.03 13.80 1.98 1.54
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
378.79 172.58 490.07 352.34 68.76
Cash Conversion Cycle (CCC)
-245.47 -31.55 -476.27 -350.36 -67.21
Capital & Investment Metrics
- - - - -
Invested Capital
316 80 0.67 -56 59
Invested Capital Turnover
0.09 0.71 18.12 -124.96 1,352.59
Increase / (Decrease) in Invested Capital
0.00 0.00 -79 -56 115
Enterprise Value (EV)
168 306 581 392 259
Market Capitalization
261 323 628 516 313
Book Value per Share
$14.98 $0.36 $0.17 $1.63 $3.62
Tangible Book Value per Share
$3.58 $0.09 ($0.08) ($1.78) $1.37
Total Capital
0.00 336 136 63 113
Total Debt
0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00
Net Debt
-94 -256 -135 -153 -54
Capital Expenditures (CapEx)
21 31 9.43 3.09 1.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-13 -22 -54 -106 -3.26
Debt-free Net Working Capital (DFNWC)
81 234 81 46 39
Net Working Capital (NWC)
81 234 81 46 39
Net Nonoperating Expense (NNE)
24 577 116 46 29
Net Nonoperating Obligations (NNO)
316 -256 -135 -119 -54
Total Depreciation and Amortization (D&A)
8.36 25 14 0.34 0.61
Debt-free, Cash-free Net Working Capital to Revenue
-44.85% -39.39% -7.49% -3.09% -0.14%
Debt-free Net Working Capital to Revenue
284.21% 416.79% 11.08% 1.34% 1.68%
Net Working Capital to Revenue
284.21% 416.79% 11.08% 1.34% 1.68%
Earnings Adjustments
- - - - -
Adjusted Basic Earnings per Share
$0.00 ($203.00) ($21.00) ($7.97) ($8.87)
Adjusted Weighted Average Basic Shares Outstanding
0.00 10.91M 13.15M 22.87M 30.56M
Adjusted Diluted Earnings per Share
$0.00 ($203.00) ($21.00) ($7.97) ($8.87)
Adjusted Weighted Average Diluted Shares Outstanding
0.00 10.91M 13.15M 22.87M 30.56M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 10.91M 13.15M 22.87M 30.56M
Normalized Net Operating Profit after Tax (NOPAT)
-35 -124 -78 -51 -99
Normalized NOPAT Margin
-123.95% -220.77% -10.68% -1.50% -4.25%
Pre Tax Income Margin
-277.99% -3,559.43% -21.09% -2.74% -4.17%
Debt Service Ratios
- - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -0.13% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Bakkt

This table displays calculated financial ratios and metrics derived from Bakkt's official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding
563,610,314.00 328,822,356.00 20,567,574.00 20,657,042.00 20,811,835.00 22,868,633.00 21,051,782.00 28,690,978.00 31,178,817.00 30,562,096.00 44,612,329.00
DEI Adjusted Shares Outstanding
22,544,413.00 13,152,894.00 20,567,574.00 20,657,042.00 20,811,835.00 22,868,633.00 21,051,782.00 28,690,978.00 31,178,817.00 30,562,096.00 44,612,329.00
DEI Earnings Per Adjusted Shares Outstanding
-1.18 -0.62 -0.80 -0.17 -0.89 0.34 -0.70 -0.55 -2.70 -0.38 -0.39
Growth Metrics
- - - - - - - - - - -
Revenue Growth
881.31% 6,364.80% 46.68% -100.00% 1,186.87% 24.71% 13.33% 0.00% -67.14% -77.14% 0.00%
EBITDA Growth
98.66% 49.27% 22.59% 90.19% -706.77% 186.45% 18.27% -346.92% -78.16% -160.60% 36.63%
EBIT Growth
97.75% 52.49% 28.16% 90.72% -371.56% 185.23% 18.11% -340.27% -78.07% -161.66% 33.07%
NOPAT Growth
97.94% 29.95% 56.90% 52.45% 47.50% 30.91% 16.02% -0.50% -2,280.06% 23.06% -73.79%
Net Income Growth
75.89% 52.57% 29.69% 87.84% 48.70% 176.33% 15.09% -268.08% -135.73% -171.74% 368.11%
EPS Growth
75.89% 52.57% 43.07% 90.51% -912.50% 160.75% 19.10% -155.56% -240.74% -136.28% 189.81%
Operating Cash Flow Growth
71.27% 181.19% -110.89% -201.91% 561.39% -364.08% 108.12% -86.14% -134.43% 88.06% -376.85%
Free Cash Flow Firm Growth
0.00% -87.66% -90.41% -75.06% -27.28% -154.13% -133.76% -250.86% -424.37% 60.61% -444.49%
Invested Capital Growth
-99.16% -144.38% -133.65% -132.30% -8,407.90% 137.63% 94.14% 402.91% 206.19% 122.54% 10,323.67%
Revenue Q/Q Growth
-21.20% 429.59% -40.33% -100.00% 0.00% -48.68% -45.78% -100.00% 0.00% -64.31% -100.00%
EBITDA Q/Q Growth
91.12% -408.85% -66.07% 86.92% -629.86% 154.53% -257.00% 28.47% -190.95% 81.45% -46.16%
EBIT Q/Q Growth
85.93% -197.67% -66.17% 86.67% -615.15% 153.80% -259.65% 28.33% -189.25% 81.37% -54.40%
NOPAT Q/Q Growth
87.05% -364.91% 30.84% -14.17% 85.70% -511.88% 15.95% -36.64% -238.69% 80.22% -65.55%
Net Income Q/Q Growth
-52.07% 72.96% -66.92% 82.28% -541.69% 140.23% -285.68% 23.20% -310.96% 87.76% 793.92%
EPS Q/Q Growth
-52.07% 72.96% -43.55% 83.15% -80.00% 239.51% -291.15% 46.76% -140.00% 85.14% 573.17%
Operating Cash Flow Q/Q Growth
-127.67% 663.52% -271.81% 61.96% 225.28% -422.53% 105.28% -971.77% 76.82% -11.84% -22.53%
Free Cash Flow Firm Q/Q Growth
-72.27% 183.10% -21.33% -59.62% -19.15% -310.76% 50.94% -80.47% -73.83% 74.41% -557.99%
Invested Capital Q/Q Growth
-98.95% -10,733.83% 36.30% 54.73% -170.95% 148.16% -109.92% 2,441.13% -5.01% 0.93% 355.50%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
124.99% 97.13% 95.61% 0.00% 101.00% 99.27% 96.52% 0.00% 95.41% 97.29% 0.00%
EBITDA Margin
-2.68% -2.58% -7.17% 0.00% -1.68% 1.79% -5.17% 0.00% -9.11% -4.74% 0.00%
Operating Margin
-4.24% -3.73% -4.32% 0.00% -0.17% -1.45% -3.20% 0.00% -12.54% -6.95% 0.00%
EBIT Margin
-4.60% -2.58% -7.19% 0.00% -1.68% 1.77% -5.20% 0.00% -9.12% -4.76% 0.00%
Profit (Net Income) Margin
-48.77% -2.49% -6.96% 0.00% -1.94% 1.52% -5.22% 0.00% -13.94% -4.78% 0.00%
Tax Burden Percent
1,195.94% 100.74% 100.21% 162.31% 119.20% 83.55% 100.20% 107.31% 153.49% 102.04% 99.65%
Interest Burden Percent
88.73% 95.67% 96.61% 79.26% 96.85% 103.31% 100.18% 100.23% 99.56% 98.41% -452.91%
Effective Tax Rate
0.00% 0.00% 0.00% 0.00% 0.00% 0.25% 0.00% 0.00% 0.00% 0.00% 0.01%
Return on Invested Capital (ROIC)
-53.82% -91.47% -116.76% 0.00% 0.00% 0.00% 0.00% 0.00% -11,870.75% -169.95% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-16.07% -92.07% -102.02% 0.00% 0.00% 0.00% 0.00% 0.00% -11,829.78% -170.19% 0.00%
Return on Net Nonoperating Assets (RNNOA)
13.33% 72.88% 76.80% 0.00% 0.00% 0.00% 0.00% 0.00% 11,597.21% 111.81% 0.00%
Return on Equity (ROE)
-40.48% -18.59% -39.95% 0.00% -104.19% -62.07% -75.53% 0.00% -273.54% -58.15% 0.00%
Cash Return on Invested Capital (CROIC)
-75.89% 0.00% 0.00% 0.00% 0.00% -538.33% 0.00% -207.00% -368.98% -317.39% -140.28%
Operating Return on Assets (OROA)
-9.27% -4.07% -10.99% 0.00% -21.68% 7.36% -27.06% 0.00% -98.61% -36.98% 0.00%
Return on Assets (ROA)
-98.37% -3.93% -10.64% 0.00% -25.02% 6.35% -27.16% 0.00% -150.70% -37.14% 0.00%
Return on Common Equity (ROCE)
-12.40% -6.34% -14.51% 0.00% -43.12% -29.52% -39.12% 0.00% -228.44% -49.51% 0.00%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
-4.79 -22 -15 -18 -2.52 -15 -13 -18 -60 -12 -20
NOPAT Margin
-2.97% -2.61% -3.02% 0.00% -0.12% -1.44% -2.24% 0.00% -8.78% -4.86% 0.00%
Net Nonoperating Expense Percent (NNEP)
-37.75% 0.60% -14.73% 8.38% -29.85% 24.63% -16.51% -5.80% -40.97% 0.24% 140.77%
Return On Investment Capital (ROIC_SIMPLE)
-3.53% -17.03% -15.02% -17.25% -4.00% -18.88% -16.15% -13.76% -53.11% -6.93% -5.53%
Cost of Revenue to Revenue
-24.99% 2.87% 4.39% 0.00% -1.00% 0.73% 3.48% 0.00% 4.59% 2.71% 0.00%
SG&A Expenses to Revenue
5.02% 2.08% 2.60% 0.00% 0.19% 1.00% 1.88% 0.00% 1.28% 4.88% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
112.46% 100.85% 99.93% 0.00% 101.14% 100.72% 99.72% 0.00% 107.81% 104.24% 0.00%
Earnings before Interest and Taxes (EBIT)
-7.42 -22 -37 -4.89 -35 19 -30 -22 -62 -12 -18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-4.33 -22 -37 -4.78 -35 19 -30 -21 -62 -12 -17
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
13.02 2.65 8.14 3.92 15.21 4.50 8.32 8.44 2.78 1.32 0.98
Price to Tangible Book Value (P/TBV)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.85 7.35 2.23 1.99
Price to Revenue (P/Rev)
0.86 0.10 0.22 0.13 0.15 0.05 0.08 0.26 0.13 0.15 0.23
Price to Earnings (P/E)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
865.60 0.00 0.00 0.00 0.00 6.74 0.00 14.24 4.38 1.90 0.98
Enterprise Value to Revenue (EV/Rev)
0.80 0.01 0.17 0.08 0.11 0.05 0.07 0.24 0.11 0.08 0.18
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.74 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.14 2.93 5.24 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.39 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.83 -0.79 -0.75 -0.86 -1.28 -1.21 -1.30 -0.82 -0.98 -0.66 -0.35
Leverage Ratio
1.53 4.63 6.25 6.48 2.69 8.25 8.93 6.25 2.46 1.54 1.44
Compound Leverage Factor
1.36 4.43 6.04 5.14 2.61 8.52 8.95 6.26 2.45 1.52 -6.52
Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.84% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 27.84% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
64.42% 56.46% 53.41% 50.51% 46.07% 45.98% 28.12% 11.02% 0.00% 0.00% 0.00%
Common Equity to Total Capital
35.58% 43.54% 46.59% 49.49% 53.93% 54.02% 44.04% 88.98% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 -0.42 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 1.13 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 -0.48 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 1.31 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
1.96 0.41 0.70 0.52 9.90 16.28 14.61 14.50 9.34 4.60 5.15
Noncontrolling Interest Sharing Ratio
69.36% 65.92% 63.69% 0.00% 58.62% 52.44% 48.20% 0.00% 16.49% 14.86% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.80 1.07 1.07 1.05 1.33 1.58 1.19 2.24 2.19 4.13 3.14
Quick Ratio
0.99 0.08 0.08 0.06 0.34 0.88 0.72 1.41 1.19 2.97 1.98
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
74 210 165 67 54 -114 -56 -101 -175 -45 -294
Operating Cash Flow to CapEx
-445.42% 2,165.61% -14,231.75% -4,599.08% 10,195.45% -77,908.46% 28,168.42% -8,421.84% -2,330.39% -1,661.13% -979.96%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -1,051.53 -2,011.58 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 100.98 -933.14 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 100.62 -944.22 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
2.02 1.58 1.53 1.50 12.87 4.17 5.20 5.18 10.81 7.76 5.10
Accounts Receivable Turnover
26.45 50.15 76.15 62.94 184.27 110.93 156.23 189.58 236.44 79.17 87.51
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
73.42 145.17 156.44 136.99 3,240.17 2,097.17 1,978.44 2,259.54 1,254.16 704.41 771.19
Accounts Payable Turnover
0.74 0.64 0.68 0.36 1.04 0.39 0.66 0.85 5.31 3.03 2.78
Days Sales Outstanding (DSO)
13.80 7.28 4.79 5.80 1.98 3.29 2.34 1.93 1.54 4.61 4.17
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
490.07 570.90 536.16 1,009.59 352.34 946.56 551.95 431.43 68.76 120.49 131.43
Cash Conversion Cycle (CCC)
-476.27 -563.62 -531.36 -1,003.80 -350.36 -943.27 -549.61 -429.51 -67.21 -115.88 -127.26
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
0.67 -71 -45 -21 -56 27 -2.66 62 59 60 272
Invested Capital Turnover
18.12 35.08 38.63 70.77 -124.96 -164.13 -155.03 178.67 1,352.59 34.95 11.23
Increase / (Decrease) in Invested Capital
-79 -232 -181 -84 -56 98 43 83 115 33 275
Enterprise Value (EV)
581 18 296 127 392 181 256 888 259 114 266
Market Capitalization
628 151 389 198 516 198 294 965 313 225 348
Book Value per Share
$0.17 $0.17 $2.32 $2.44 $1.63 $1.93 $1.68 $3.99 $3.62 $5.59 $7.94
Tangible Book Value per Share
($0.08) ($0.04) ($1.12) ($0.99) ($1.78) ($1.17) ($1.53) $1.54 $1.37 $3.29 $3.92
Total Capital
136 131 103 102 63 82 80 129 113 171 354
Total Debt
0.00 0.00 0.00 0.00 0.00 0.00 22 0.00 0.00 0.00 0.00
Total Long-Term Debt
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-135 -207 -148 -123 -153 -55 -60 -92 -54 -111 -82
Capital Expenditures (CapEx)
1.53 1.77 0.46 0.55 0.31 0.13 0.02 0.55 0.46 0.73 1.51
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-54 -115 -68 -67 -106 -21 -43 -14 -3.26 -5.48 -5.21
Debt-free Net Working Capital (DFNWC)
81 92 80 56 46 34 40 67 39 95 66
Net Working Capital (NWC)
81 92 80 56 46 34 17 67 39 95 66
Net Nonoperating Expense (NNE)
74 -1.01 20 -11 38 -32 17 5.47 35 -0.20 -100
Net Nonoperating Obligations (NNO)
-135 -202 -148 -123 -119 -55 -60 -66 -54 -111 -82
Total Depreciation and Amortization (D&A)
3.09 0.06 0.12 0.11 0.06 0.22 0.15 0.15 0.08 0.07 1.05
Debt-free, Cash-free Net Working Capital to Revenue
-7.49% -7.32% -3.93% -4.37% -3.09% -0.57% -1.16% -0.37% -0.14% -0.36% -0.34%
Debt-free Net Working Capital to Revenue
11.08% 5.87% 4.62% 3.66% 1.34% 0.93% 1.06% 1.79% 1.68% 6.26% 4.39%
Net Working Capital to Revenue
11.08% 5.87% 4.62% 3.66% 1.34% 0.93% 0.46% 1.79% 1.68% 6.26% 4.39%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
($2.00) ($1.86) ($2.67) ($0.45) ($0.81) $1.18 ($2.16) ($1.15) ($2.76) ($0.41) $1.96
Adjusted Weighted Average Basic Shares Outstanding
13.15M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M
Adjusted Diluted Earnings per Share
($2.00) ($1.86) ($2.67) ($0.45) ($0.81) $1.13 ($2.16) ($1.15) ($2.76) ($0.41) $1.94
Adjusted Weighted Average Diluted Shares Outstanding
13.15M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M
Adjusted Basic & Diluted Earnings per Share
($2.00) $0.00 $0.00 $0.00 ($0.81) $0.00 $0.00 $0.00 ($2.76) $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
13.15M 20.57M 20.66M 20.81M 22.87M 21.05M 28.69M 31.18M 30.56M 44.61M 45.07M
Normalized Net Operating Profit after Tax (NOPAT)
-4.51 -18 -15 -17 -1.93 -15 -13 -14 -60 -12 -20
Normalized NOPAT Margin
-2.79% -2.08% -2.90% 0.00% -0.09% -1.42% -2.24% 0.00% -8.77% -4.86% 0.00%
Pre Tax Income Margin
-4.08% -2.47% -6.95% 0.00% -1.63% 1.82% -5.21% 0.00% -9.09% -4.69% 0.00%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -566.77 -430.58 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -244.19 -353.68 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -567.13 -441.66 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 -244.55 -364.76 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% -2.42% -1.31% -1.81% 0.00% 0.00% -3.44% -4.75% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Bakkt’s financial statements show a highly volatile business with improving reported earnings in Q2 2026, but limited evidence of sustainable operating profitability. Revenue swung from $1.07 billion in Q1 2025 to $243.6 million in Q1 2026, then was reported at zero in Q2 2026. The sharp fluctuations, along with restated prior-period results, make it difficult to identify a consistent underlying growth trend.

Profitability also remains difficult to interpret. Bakkt reported $80.8 million of consolidated net income in Q2 2026, compared with an $11.7 million loss in Q1. However, the company reported a $17.3 million loss attributable to common shareholders, while the Q2 income statement also shows unusual relationships between consolidated income, common earnings and earnings per share. The quarter’s $95.1 million negative non-cash adjustment further indicates that reported earnings were heavily affected by non-operating or non-cash items rather than recurring operations.

Liquidity is better than in earlier periods, but cash usage remains a concern. Cash and equivalents declined from $80.0 million at the end of Q1 2026 to $50.0 million at the end of Q2, while total cash and restricted cash stood at $71.3 million. Bakkt used $14.8 million in operating activities and $14.4 million in investing activities during Q2, resulting in a $28.8 million quarterly decline in cash. The company’s balance sheet expanded sharply, with total assets increasing from $213.4 million to $403.6 million, largely because of increases in goodwill and other noncurrent assets.

  • Reported earnings improved sequentially: consolidated net income rose from a $11.7 million loss in Q1 2026 to $80.8 million of income in Q2 2026.
  • Leverage appears manageable: total liabilities were $49.2 million at June 30, 2026, compared with $354.4 million of reported equity, and the balance sheet showed no material short-term or long-term debt categories.
  • Liquidity remains meaningful: Bakkt held $50.0 million of cash and $21.3 million of restricted cash at the end of Q2 2026, versus $43.5 million and $39.3 million, respectively, at the end of Q2 2025.
  • Asset growth may reflect strategic expansion: goodwill increased from $64.7 million in Q1 2026 to $156.7 million in Q2, while intangible assets and other noncurrent operating assets also rose sharply. Investors should determine whether these increases came from an acquisition or another corporate transaction.
  • Financing was important to liquidity: Bakkt generated $66.8 million from financing activities in Q1 2026, primarily through common-equity issuance, but financing contributed only $451,000 in Q2.
  • Share counts have risen substantially: weighted average basic shares increased from 20.6 million in Q1 2024 to 45.1 million in Q2 2026, indicating significant dilution over the period.
  • Operating cash flow remains negative: Bakkt reported negative operating cash flow in Q3 2024, Q4 2024, Q1 2025, Q3 2025, Q4 2025, Q1 2026 and Q2 2026. The Q2 2026 operating cash outflow was $14.8 million.
  • Recurring profitability has not been established: Q2 2026 revenue was reported at zero, producing a $7.0 million gross loss and a $19.6 million operating loss before non-operating items.
  • Results are highly inconsistent: quarterly revenue ranged from zero to more than $2.0 billion across the supplied periods, while several periods included large other operating expenses, restructuring charges, discontinued operations or other gains and losses.
  • Cash burn could pressure future financing: with $28.8 million of cash used during Q2 2026 and only $50.0 million of unrestricted cash reported at quarter-end, Bakkt may need to reduce spending, monetize investments or raise additional capital if operating losses continue.
10/17/26 10:11 AM ETAI Generated. May Contain Errors.

Bakkt Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Bakkt's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Bakkt's net income appears to be on an upward trend, with a most recent value of -$132.23 million in 2025, falling from -$79.61 million in 2020. The previous period was -$103.45 million in 2024. Find out what analysts predict for Bakkt in the coming months.

Bakkt's total operating income in 2025 was -$147.84 million, based on the following breakdown:
  • Total Gross Profit: $2.26 billion
  • Total Operating Expenses: $2.41 billion

Over the last 5 years, Bakkt's total revenue changed from $28.50 million in 2020 to $2.34 billion in 2025, a change of 8,095.3%.

In the past 11 quarters, Bakkt's cash and equivalents has ranged from $23.01 million in Q1 2025 to $79.98 million in Q1 2026, and is currently $49.98 million as of their latest financial filing in Q2 2026.

Bakkt had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2020.

Over the last 5 years, Bakkt's book value per share changed from 14.98 in 2020 to 3.62 in 2025, a change of -75.9%.



Financial statements for NYSE:BKKT last updated on 8/10/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners